Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Novo Nordisk on Wednesday stated KING88BET a third-quarter defeat for sale of its own smash hit weight-loss medication Wegovy as well as tightened its own 2024 full-year development assistance. Business allotments leapt at an early stage Wednesday as well as were actually final up 7.7% at 9:02 a.m. Greater london opportunity. The Danish pharmaceutical titan KING88bet Login Alternatif stated that its own web revenue in the 3rd fourth struck 27.3 billion Danish kroner ($3.92 billion), over an LSEG accumulation quote of 26.95 billion Danish kroner. Novo Nordisk included that purchases of Wegovy were actually 79% greater year-on-year in the 3rd fourth, being available in at 17.3 billion Danish kroner. This was actually over the 15.9 billion Danish kroner expert possessed been actually anticipating inning accordance with a company-compiled agreement, Reuters stated. The business tightened its own KING88bet link alternatif purchases development overview for the complete yea